Bas Jasperse

Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma

Joris L. Vos, Joris B.W. Elbers, Oscar Krijgsman et al. · Nature Communications · 2021 · 336 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Whole-Brain T1 Mapping in Multiple Sclerosis: Global Changes of Normal-appearing Gray and White Matter

Hugo Vrenken, Jeroen J.G. Geurts, Dirk L. Knol et al. · Radiology · 2006 · 206 citations

Life Sciences, Neurology, Neuroscience +15

The tubarial salivary glands: A potential new organ at risk for radiotherapy

Matthijs H. Valstar, Bernadette S. de Bakker, Roel J.H.M. Steenbakkers et al. · Radiotherapy and Oncology · 2020 · 148 citations · Full text

Medicine, Nuclear Medicine, Oncology +16

Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis

Daniel R. Altmann, Bas Jasperse, Frederik Barkhof et al. · Neurology · 2008 · 100 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Long-term clinical outcome of primary progressive MS: Predictive value of clinical and MRI data

Jaume Sastre‐Garriga, Gordon Ingle, Marco Rovaris et al. · Neurology · 2005 · 68 citations

Life Sciences, Neurology, Neuroscience +17